FDA Inspection 1218049 — Lupin Limited (Unit II)
The FDA completed an inspection of Lupin Limited (Unit II) on August 11, 2023 in Mandideep. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mandideep (India)